PMAM
TEVA icon

Picton Mahoney Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Picton Mahoney Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.1M Buy
+1,000,000
New +$32.2M 0.22% 71

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Picton Mahoney Asset Management's TEVA Position: Q1 2026 in Review

Picton Mahoney Asset Management increased its Teva Pharmaceuticals (TEVA) stake by 40% in Q1 2026, buying an estimated $7.38M and bringing the position to 810,218 shares worth $24.4M. The position accounts for 0.18% of the portfolio, ranked #95.

Picton Mahoney Asset Management first reported a position in TEVA in Q2 2013 and has held it in 15 quarters since. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Picton Mahoney Asset Management held 810,218 shares of Teva Pharmaceuticals worth $24.4M as of Q1 2026.
  • Picton Mahoney Asset Management bought 229,467 Teva Pharmaceuticals shares in Q1 2026, an estimated $7.38M.
  • Teva Pharmaceuticals made up 0.18% of Picton Mahoney Asset Management's portfolio in Q1 2026, its #95 holding.
  • Picton Mahoney Asset Management first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2026, filed 13 May 2026.